Comparison of Iodixanol and Ioversol for the Prevention of Contrast-Induced Nephropathy in Diabetic Patients After Coronary Angiography or Angioplasty;Comparación de iodixanol frente a ioversol en la prevención de la nefropatía por contraste tras coronariografía o angioplastia en pacientes diabéticos

Revista Espanola de Cardiologia

Volumn 62, Issue 12, 2009, Pages 1373-1380

  Hernández, Felipe ^a   Mora, Laura ^a   García Tejada, Julio ^a   Velázquez, Maite ^a   Gómez Blázquez, Iván ^a   Bastante, Teresa ^a   Albarrán, Agustín ^a   Andreu, Javier ^a   Tascón, Juan ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Contrast media; Coronary angiography; Diabetes mellitus; Imaging; Kidney

Indexed keywords

IODIXANOL; IOVERSOL;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RISK REDUCTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CREATININE; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; KIDNEY DISEASES; MALE; PROSPECTIVE STUDIES; TRIIODOBENZOIC ACIDS;

EID: 75449093858     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)73122-7     Document Type: Article

References (32)

1. Nash K., Hafeez A., and Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 39 (2002) 930-936
2. Hou S.H., Bushinsky D.A., Wish J.B., Cohen J.J., and Harrington J.T. Hospital-acquired renal insufficiency: a prospective study. Am J Med 74 (1983) 243-248
3. Rihal C.S., Textor S.C., Grill D.E., Berger P.B., Ting H.H., Best P.J., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
4. Manske C.L., Sprafka J.M., Strony J.T., and Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89 (1990) 615-620
5. Rudnick M.R., Goldfarb S., Wexler L., Ludbrook P.A., Murphy M.J., Halpern E.F., et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 47 (1995) 254-261
6. McCullough P.A., Adam A., Becker C.R., Davidson C., Lameire N., Stacul F., et al., on behalf of the CIN Consensus Working Panel. Risk prediction of contrast-induced nephropathy. Am J Cardiol 98 (2006) K27-K36
7. Mehran R., Aymong E.D., Nikolsky E., Lasic Z., Iakovou I., Fahy M., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44 (2004) 1393-1399
8. Dangas G., Iakovou I., Nikolsky E., Aymong E.D., Mintz G.S., Kipshidze N.N., et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95 (2005) 13-19
9. Levy E.M., Viscoli C.M., and Horwitz R.I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275 (1996) 1489-1494
10. Weisbord S.D., Chen H., Stone R.A., Kip K.E., Fine M.J., Saul M.I., et al. Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol 17 (2006) 2871-2877
11. Bouzas-Mosquera A., Vázquez-Rodríguez J.M., Calviño-Santos R., Peteiro-Vázquez J., Flores-Ríos X., Marzoa-Rivas R., et al. Nefropatía inducida por contraste y fracaso renal agudo tras cateterismo cardiaco urgente: incidencia, factores de riesgo y pronóstico. Rev Esp Cardiol 60 (2007) 1026-1034
12. Thomsen H.S., and Morcos S.K. ESUR guidelines on contrast media. Abdom Imaging 31 (2006) 131-140
13. Middleton R.J., Foley R.N., Hegarty J., Cheung C.M., McElduff P., Gibson J.M., et al. The unrecognized prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant 21 (2006) 88-92
14. Bachorzewska-Gajewska H., Malyszko J., Malyszko J.S., Musial W., and Dobrzycki S. Undiagnosed renal impairment in patients with and without diabetes with normal serum creatinine undergoing percutaneous coronary intervention. Nephrology (Carlton) 11 (2006) 549-554
15. New J.P., Middleton R.J., Klebe B., Farmer C.K., de Lusignan S., Stevens P.E., et al. Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice. Diabet Med 24 (2007) 364-369
16. Aspelin P., Aubry P., Fransson S.G., Strasser R., Willenbrock R., and Berg K.J. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348 (2003) 491-499
17. Jo S.H., Youn T.J., Koo B.K., Park J.S., Kang H.J., Cho Y.S., et al. Renal toxicity evaluation and comparison between Visipaque (iodixanol) and Hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol 48 (2006) 924-930
18. Nie B., Cheng W.J., Li Y.F., Cao Z., Yang Q., Zhao Y.X., et al. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention. Cathet Cardiovasc Intervent 72 (2008) 958-965
19. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
20. Barrett B.J., and Carlisle E.J. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188 (1993) 171-178
21. McCullough P.A., Bertrand M.E., Brinker J.A., and Stacul F. A meta-analysis of the renal safety of isosmolar iodixanol compared to low-osmolar contrast media. J Am Coll Cardiol 48 (2006) 692-699
22. Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Califf R.M., Casey Jr. D.E., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50 (2007) e1-e157
23. Solomon R.J., Natarajan M.K., Doucet S., Sharma S.K., Staniloae C.S., Katholi R.E., et al. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 115 (2007) 3189-3196
24. Davidson C.J., Hlatky M., Morris K.G., Pieper K., Skelton T.N., Schwab S.J., et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med 110 (1989) 119-124
25. Schweiger M.J., Chambers C.E., Davidson C.J., Blankenship J., Bhalla N.P., Block P.C., et al. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv 69 (2007) 135-140
26. Perkins B.A., Nelson R.G., Ostrander B.E., Blouch K.L., Krolewski A.S., Myers B.D., et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol 16 (2005) 1404-1412
27. De Agustín J.A., Carda R., Manzano Mdel C., Ruiz-Mateos B., García-Rubira J.C., Fernández-Ortiz A., et al. Aclaramiento de creatinina y nefropatía por contraste en pacientes con creatinina normal. Rev Esp Cardiol 60 (2007) 772-776
28. Hardiek K.J., Katholi R.E., Robbs R.S., and Katholi C.E. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography. J Diabetes Complicat 22 (2008) 171-177
29. National Kidney Foundation. Executive summary. Am J Kidney Dis 43 Suppl 1 (2004) 16-33
30. Bartholomew B.A., Harjai K.J., Dukkipati S., Boura J.A., Yerkey M.W., Glazier S., et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93 (2004) 1515-1519
31. Ibrahim H., Mondress M., Tello A., Fan Y., Koopmeiners J., and Thomas W. An alternative formula to the Cockcroft-Gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetes. J Am Soc Nephrol 16 (2005) 1051-1060
32. Toprak O., Cirit M., Yesil M., Byrne D.W., Postaci N., Bayata S., et al. Metabolic syndrome as a risk factor for contrast-induced nephropathy in non-diabetic elderly patients with renal impairment. Kidney Blood Press Res 29 (2006) 2-9